CD163 and inflammatory bowel disease: Because CD163 antibodies exhibited some non-macrophage labeling, we confirmed the increase in M2 macrophages from IBD vs. Control arteries (but not in macrophage-depleted mice) using a CD206 antibody, where quantitation showed a two-fold increase in CD206+ fluorescence area with IBD (p < 0.05, data not shown).